Author

Ekaterina Shevchenko

Institute of Pharmacy, Pharmaceutical/Medicinal Chemistry and Tübingen Center for Academic Drug Discovery (TüCAD2), Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Amelie Menge· 1 shared Andreas C. JoergeriD· 1 shared Andreas KrämeriD· 1 shared Antti PosoiD· 1 shared Astrid Kaiser· 1 shared Benedict-Tilman BergeriD· 1 shared Dimitrios-Ilias BalourdasiD· 1 shared Ismahan Abdi· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Amelie Menge

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BiochemistrybioRxivNov 24, 2023

Development of selective pyridopyrimidin-7(8H)-one-based Mammalian STE20-like (MST3/4) kinase inhibitors

Marcel Rak, Amelie Menge, Roberta Tesch…·Stefan Knapp

This study develops selective MST3/4 kinase inhibitors and demonstrates their distinct cellular effects compared to MST1/2 inhibition.

DOI 10.1021/acs.jmedchem.3c02217

experimental assaydrug response / drug discovery

𝕏 PostBluesky